Floatz logo

MG-2

Alcoholic Fatty Liver Disease

PharmaKingPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Alcoholic Fatty Liver Disease cohort.

Asset / SponsorPhaseRating
mg-1
PharmaKing
Phase 2B
Metadoxine
PharmaKing
Phase 2B
URSODEOXYCHOLIC ACID
Phenomen Pharma
N/AD

Same molecule, other indications

MG-2 is also rated in:

alcoholic hepatitisDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →